Articular and Extra-Articular Benefits in ACR20 Non-responders at Week 104 Treated With Apremilast: Pooled Analysis of Three Randomized Controlled Trials

INTRODUCTION: PALACE 1, 2, and 3 were phase 3 studies aimed to evaluate apremilast efficacy and safety in patients with active psoriatic arthritis (PsA) despite prior treatment with conventional disease-modifying anti-rheumatic drugs and/or biologics. The pooled analysis reported here further charac...

Descripción completa

Detalles Bibliográficos
Autores principales: Mease, Philip J., Gladman, Dafna D., Kavanaugh, Arthur, McGonagle, Dennis, Nash, Peter, Guerette, Benoit, Nakasato, Priscila, Brunori, Michele, Teng, Lichen, McInnes, Iain B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572179/
https://www.ncbi.nlm.nih.gov/pubmed/34536218
http://dx.doi.org/10.1007/s40744-021-00369-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572179/
https://www.ncbi.nlm.nih.gov/pubmed/34536218
http://dx.doi.org/10.1007/s40744-021-00369-x

Ejemplares similares